Sanara MedTech (SMTI) Change in Receivables (2010 - 2026)

Sanara MedTech (SMTI) has 16 years of Change in Receivables data on file, last reported at $1.7 million in Q1 2026.

• Quarterly Change in Receivables rose 564.13% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (down 35.62% YoY) and the FY2025 annual result came in at $114690.0, down 97.46% from the prior year.
• Change in Receivables advanced to $1.7 million in Q1 2026, from -$30269.0 in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $1.7 million in Q4 2024 to a low of -$415895.0 in Q3 2022.
• A 5-year average of $612064.6 and a median of $607795.0 in 2022 frame the typical range for Change in Receivables.
• Annual changes were most pronounced in 2022 — Change in Receivables surged 1704.67% — and 2023, when it sank 162.54%.
• Tracing SMTI's Change in Receivables over 5 years: stood at $1.5 million in 2022, then slumped by 31.28% to $1.0 million in 2023, then surged by 68.53% to $1.7 million in 2024, then tumbled by 101.75% to -$30269.0 in 2025, then soared by 5747.14% to $1.7 million in 2026.
• The last three Change in Receivables figures came in at $1.7 million (Q1 2026), -$30269.0 (Q4 2025), and $270045.0 (Q3 2025), per Business Quant data.